• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.10% Nasdaq Down1.82%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NCM
    3.31 Down 0.24(6.76%) Feb 8, 4:00PM EST
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Net Income (30,745) (26,877) (27,739) (40,285)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation88  103  138  121  
    Adjustments To Net Income4,597  4,077  4,343  14,261  
    Changes In Accounts Receivables(1,190)(155)(401)(731)
    Changes In Liabilities1,456  (9,051)7,011  1,244  
    Changes In Inventories(1,508)(6,694)(19,317)(6,859)
    Changes In Other Operating Activities(1,520)(173)689  (1,349)
    Total Cash Flow From Operating Activities (28,822) (38,770) (35,276) (33,598)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(268)(103)(61)(290)
    Investments -   -  11,508  22,593  
    Other Cash flows from Investing Activities -   -   -   -  
    Total Cash Flows From Investing Activities (268) (103) 11,447   22,303  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -   -  
    Sale Purchase of Stock9  1,341  118,381  1,447  
    Net Borrowings -   -   -   -  
    Other Cash Flows from Financing Activities -  (15) -   -  
    Total Cash Flows From Financing Activities 9   1,326   118,381   1,447  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents (29,081) (37,547) 94,552   (9,848)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.